WS #13305
AstraZeneca and Bristol Myers Squibb in early merger talks, potentially creating a ~$400bn pharma giant; AstraZeneca shares drop on skepticism.
AstraZeneca-Bristol Myers merger talks
AstraZeneca and Bristol Myers Squibb in early merger talks, potentially creating a ~$400bn pharma giant; AstraZeneca shares drop on skepticism.